Zhongjie Liu

Dr. Zhongjie Liu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ZLZhongjie Liu
Zhongjie Liu
WZWei Zhao
Wei Zhao
PYPengfei Yuan
Pengfei Yuan
PZPian Zhu
Pian Zhu
KFKeke Fan
Keke Fan
SXShiyuan Xu
Shiyuan Xu

18 March 2022 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PYPengfei Yuan
Pengfei Yuan
FSFuhu Song
Fuhu Song
PZPian Zhu
Pian Zhu
KFKeke Fan
Keke Fan
QLQinming Liao
Qinming Liao
ZLZhongjie Liu
Zhongjie Liu

19 July 2024 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
QLQinming Liao
Qinming Liao
YYYimei Yang
Yimei Yang
YLYilu Li
Yilu Li
JZJun Zhang
Jun Zhang
KFKeke Fan
Keke Fan
ZLZhongjie Liu
Zhongjie Liu
Background: Painful diabetic neuropathy (PDN) is closely linked to inflammation, which has been demonstrated to be associated with pyroptosis. Emerging evidence has implicated TANK-binding kinase 1 (TBK1) in various inflammatory diseases. However, it remains unknown whether activated TBK1 causes hyperalgesia via pyroptosis. Methods: PDN mice model of type 1 or type 2 diabetic was induced by C57BL/6J or BKS-DB mice with Lepr gene mutation. For type 2 diabetes PDN model, TBK1-siRNA, Caspase-1 inhibitor Ac-YVAD-cmk or TBK1 inhibitor amlexanox (AMX) were delivered by intrathecal injection or intragastric administration. The pain threshold and plantar skin blood perfusion were evaluated through animal experiments. The assessments of spinal cord, dorsal root ganglion, sciatic nerve, plantar skin and serum included western blotting, immunofluorescence, ELISA, and transmission electron microscopy. Results: In the PDN mouse model, we found that TBK1 was significantly activated in the spinal dorsal horn (SDH) and mainly located in microglia, and intrathecal injection of chemically modified TBK1-siRNA could improve hyperalgesia. Herein, we described the mechanism that TBK1 could activate the noncanonical nuclear factor κB (NF-κB) pathway, mediate the activation of NLRP3 inflammasome, trigger microglia pyroptosis, and ultimately induce PDN, which could be reversed following TBK1-siRNA injection. We also found that systemic administration of AMX, a TBK1 inhibitor, could effectively improve peripheral nerve injury. These results revealed the key role of TBK1 in PDN and that TBK1 inhibitor AMX could be a potential strategy for treating PDN. Conclusions: Our findings revealed a novel causal role of TBK1 in pathogenesis of PDN, which raises the possibility of applying amlexanox to selectively target TBK1 as a potential therapeutic strategy for PDN.

19 May 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
ZFZhiye Feng
Zhiye Feng
FLFuye Li
Fuye Li
ZLZhiqiang Lin
Zhiqiang Lin
JLJian Liu
Jian Liu
XCXi Chen
Xi Chen
ZLZhongjie Liu
Zhongjie Liu
Background: Diabetic peripheral neuropathic pain (DPNP) is one of the most common complications in diabetic patients. Current treatment strategies primarily focus on blood glucose control and pain relief, but they often yield limited effects. Ferroptosis, a regulated form of cell death driven by lipid peroxidation and iron imbalance, plays a crucial role in various diseases, including neuropathic pain.Methods: In this study, we employed a combined bioinformatics and machine learning approach to identify genes most strongly associated with DPNP and ferroptosis. Subsequently, we established a DPNP mouse model via streptozotocin (STZ) injection and a high‐glucose‐induced SH‐SY5Y cell injury model. ALOX15 was knocked down in the in vitro model using siRNA transfection.Results: Bioinformatics analysis identified ALOX15 as a hub gene linking DPNP and ferroptosis. In both in vivo and in vitro DPNP models, ALOX15 expression was significantly upregulated and correlated with ferroptosis biomarkers. Knockdown of ALOX15 in the cellular model mitigated high‐glucose‐induced ferroptosis, reduced lipid peroxidation and free iron ion accumulation, and restored cell viability.Conclusion: In conclusion, ALOX15 contributes to the onset and progression of DPNP by promoting ferroptosis, and its knockdown effectively suppresses ferroptosis, providing a novel target and strategy for DPNP treatment.

10 March 2025 in The FASEB Journal
Verified
Journal Article
Closed access
XWXinhui Wang
Xinhui Wang
YLYumiao Lin
Yumiao Lin
LYLingchen Yan
Lingchen Yan
BWBinqi Wu
Binqi Wu
KZKechen Zhu
Kechen Zhu
ZLZhongjie Liu
Zhongjie Liu

25 March 2025 in Neuroscience
Verified
Journal Article
Closed access
YBYongsheng Bian
Yongsheng Bian
YYYimei Yang
Yimei Yang
JCJun Chen
Jun Chen
JLJian Liu
Jian Liu
YTYan Tao
Yan Tao
LHLijin Huang
Lijin Huang